MDNA Life Sciences Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 3, 2027The maintenance fee for Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer (US 10,400,290) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
Recent changes
- 1 term has ended since Aug 23, 2026
- Sep 1 US 11,111,546 3.4 KB mitochondrial DNA deletion for use in the detection of cancer · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 4 of 4
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,907,213 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers In force · USPTO record | In force | USPTO record | |
| US 10,400,290 | Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer In force · USPTO record | In force | USPTO record | |
| US 10,266,899 | Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor In force · USPTO record | In force | USPTO record | |
| US 8,008,008 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 4: 2 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 4 no status recorded
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 17/415,507 | Mitochondrial DNA Deletions Associated with Endometriosis | Dec 20, 2019 | Abandoned |
| 16/558,108 | Sep 1, 2019 | No status recorded | |
| 16/386,381 | Apr 17, 2019 | No status recorded | |
| 16/057,052 | Aug 7, 2018 | No status recorded | |
| 15/347,601 | Nov 9, 2016 | No status recorded |